Qihe Biotech Funding: $91M Raised, Series A (2024)
Qihe Biotech is based in Suzhou, China. It has raised $91M in total funding. Latest round: Series A.
Qihe Biotech funding overview
Qihe Biotech is based in Suzhou, China. Qihe Biotech has raised $91M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2024. The round record for Qihe Biotech runs through 2024; nothing later has been disclosed. Investors on record include Apricot Capital, Source Code Capital, Gaorong Ventures, CD Capital, Beijing Medical and Health Care Industry Investment Fund, Beijing Changping Technology Innodevelop Group and 4 others. 10 distinct backers are named across the disclosed rounds.
Qihe Biotech at a glance
Total raised
$91M
Latest round
Series A
Latest round date
December 2024
Headquarters
Suzhou, China
Notable investors
Apricot Capital, Source Code Capital, Gaorong Ventures, CD Capital, Beijing Medical and Health Care Industry Investment Fund, Beijing Changping Technology Innodevelop Group, Mingzhe Capital, CSSD Capital
Frequently asked about Qihe Biotech funding
How much has Qihe Biotech raised?
Qihe Biotech has raised $91M in total disclosed funding across the rounds on record.
Who has invested in Qihe Biotech?
Apricot Capital, Source Code Capital, Gaorong Ventures, CD Capital, Beijing Medical and Health Care Industry Investment Fund, Beijing Changping Technology Innodevelop Group are named among the investors backing Qihe Biotech.
What was the latest Qihe Biotech funding round?
The most recent disclosed round is a Series A, announced in December 2024.
Where is Qihe Biotech based?
Qihe Biotech is based in Suzhou, China.
When did Qihe Biotech last raise?
The last disclosed Qihe Biotech round closed in December 2024 at Series A.
Round data for Qihe Biotech is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Suzhou and backer lists below.